Evidence map›Paper›PMID 27768780›Full record

ArticlePloS one2016

Over Expression of NANOS3 and DAZL in Human Embryonic Stem Cells.

Sarita Panula, Ahmed Reda, Jan-Bernd Stukenborg, Cyril Ramathal, Meena Sukhwani, Halima Albalushi, Daniel Edsgärd, Michiko Nakamura, Olle Söder, Kyle E Orwig and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Transcriptional control of human gametogenesis.Human reproduction update · 2022
    Article
  8. Article
  9. In focus in HCB.Histochemistry and cell biology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Pluripotent Cell Models for Gonadal Research.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Sarita PanulaDivision of Obstetrics and Gynecology, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Huddinge, SE-141 86, Stockholm, Sweden.
Ahmed RedaPediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Jan-Bernd StukenborgPediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Cyril RamathalDepartment of Genetics and Department of Obstetrics and Gynecology, Institute for Stem Cell Biology and Regenerative Medicine, Center for Reproductive and Stem Cell Biology, Stanford University, Stanford, CA, 94305, United States of America.
Meena SukhwaniDepartment of Obstetrics, Gynaecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, PA, 15213, United States of America.
Halima AlbalushiPediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Daniel EdsgärdDepartment of Cell and Molecular Biology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Michiko NakamuraCenter for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
Olle SöderPediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Kyle E OrwigDepartment of Obstetrics, Gynaecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, PA, 15213, United States of America.
Shinya YamanakaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
Renee A Reijo PeraDepartment of Genetics and Department of Obstetrics and Gynecology, Institute for Stem Cell Biology and Regenerative Medicine, Center for Reproductive and Stem Cell Biology, Stanford University, Stanford, CA, 94305, United States of America.
Outi HovattaDivision of Obstetrics and Gynecology, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Huddinge, SE-141 86, Stockholm, Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SEStanford University · USUniversity of Pittsburgh · USGladstone Institutes · USKyoto University · JP

Funding

Stanford University Center for Reproductive and Stem Cell biologyU54HD068158 · NICHD · STANFORD UNIVERSITY · PI HSUEH, AARON · 2011 to 2013
$5.0M
Stanford University Center for Reproductive and Stem Cell biologyP50HD068158 · NICHD · STANFORD UNIVERSITY · PI FULLER, MARGARET T · 2014 to 2015
$3.3M
NICHD NIH HHS P50 HD068158NICHD NIH HHS U54 HD068158
6 · The paper itself

Abstract

The mechanisms underlying human germ cell development are largely unknown, partly due to the scarcity of primordial germ cells and the inaccessibility of the human germline to genetic analysis. Human embryonic stem cells can differentiate to germ cells in vitro and can be genetically modified to study the genetic requirements for germ cell development. Here, we studied NANOS3 and DAZL, which have critical roles in germ cell development in several species, via their over expression in human embryonic stem cells using global transcriptional analysis, in vitro germ cell differentiation, and in vivo germ cell formation assay by xenotransplantation. We found that NANOS3 over expression prolonged pluripotency and delayed differentiation. In addition, we observed a possible connection of NANOS3 with inhibition of apoptosis. For DAZL, our results suggest a post-transcriptional regulation mechanism in hES cells. In addition, we found that DAZL suppressed the translation of OCT4, and affected the transcription of several genes associated with germ cells, cell cycle arrest, and cell migration. Furthermore, DAZL over expressed cells formed spermatogonia-like colonies in a rare instance upon xenotransplantation. These data can be used to further elucidate the role of NANOS3 and DAZL in germ cell development both in vitro and in vivo.

Indexed as

Cell DifferentiationEmbryonic Stem CellsFemaleGene ExpressionGerm CellsHeterograftsHumansMaleRNA-Binding ProteinsRNA, MessengerTranscription, GeneticDAZL protein, humanNANOS3 protein, humanRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID27768780
PMCPMC5074499
OpenAlexW2535821507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.